RESEARCH ARTICLESInfluence of First-Pass Effect on Availability of Drugs on Oral Administration
REFERENCES (8)
- et al.
J. Pharm. Sci.
(1969) - et al.
J. Pharm. Sci.
(1969) - et al.
ibid.
(1967) - et al.
ibid.
(1968)
Cited by (233)
Antimicrobial releasing hydrogel forming microneedles
2023, Biomaterials AdvancesThe anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics
2023, International ImmunopharmacologyLipid nanocapsules enhance the transdermal delivery of drugs regardless of their physico-chemical properties
2022, International Journal of PharmaceuticsCitation Excerpt :LNCs generally shine where they deliver bioactives with known oral or parenteral formulation or application problems. A substantial number of newly developed drugs possesses physico-chemical properties and modes of action that can lead to unwanted systemic side effects while delivered by the oral route and by the subsequent passage through the gastrointestinal system (Gibaldi et al., 1971; Hauss, 2007). An alternative approach can be found in a topical administration of the drugs in question (Madhusudhan et al., 2020).
Hypothesis: Can drug-loaded platelets be used as delivery vehicles for blood-brain barrier penetration?
2019, Medical HypothesesCitation Excerpt :The most common methods of treatment for ischemic strokes include medications such as aspirin, and an IV injection of a tissue plasminogen activator [14] that have proven to be effective if they are given within 3–4 h of the detection of the clot, however these medications are entering the systemic circulation and will therefore have a myriad of side effects [15]. Oral medication undergoes first pass hepatic metabolism, indicating that their onset of action is slower compared to other methods of drug delivery, and a smaller amount of the drug will reach the site of action [16]. Platelets, tiny cell fragments of megakaryocytes, are an important component of blood that cross the blood–brain barrier easily during times of vascular disturbance [17].
Microneedles with Two-Stage Glucose-Sensitive Controlled Release for Long-Term Insulin Delivery
2023, ACS Biomaterials Science and Engineering